Last reviewed · How we verify
GSK Biologicals' HPV vaccine 580299 — Competitive Intelligence Brief
marketed
Biologic
Live · refreshed every 30 min
Target snapshot
GSK Biologicals' HPV vaccine 580299 (GSK Biologicals' HPV vaccine 580299) — GlaxoSmithKline.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| GSK Biologicals' HPV vaccine 580299 TARGET | GSK Biologicals' HPV vaccine 580299 | GlaxoSmithKline | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- GSK Biologicals' HPV vaccine 580299 CI watch — RSS
- GSK Biologicals' HPV vaccine 580299 CI watch — Atom
- GSK Biologicals' HPV vaccine 580299 CI watch — JSON
- GSK Biologicals' HPV vaccine 580299 alone — RSS
Cite this brief
Drug Landscape (2026). GSK Biologicals' HPV vaccine 580299 — Competitive Intelligence Brief. https://druglandscape.com/ci/gsk-biologicals-hpv-vaccine-580299. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab